(Q24240527)

26 October 2023

Mariona Pinart

2

Mariona

Pinart

1 reference

26 October 2023

Maxine E Whitton

1

Maxine E

Whitton

1 reference

26 October 2023

Jonathan Batchelor

series ordinal

3

author given names

Jonathan

author last names

Batchelor

1 reference

26 October 2023

Clare Lushey

series ordinal

4

author given names

Clare

author last names

Lushey

1 reference

26 October 2023

Urbà González

series ordinal

6

author given names

Urbà

author last names

González

1 reference

Cochrane Database of Systematic Reviews

26 October 2023

publication date

20 January 2010

0 references

published in

0 references

cites work

A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Tacalcitol and narrow-band phototherapy in patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Clinical observation on the effect of Zengse Pill in treating patients with vitiligo of qi-stagnancy and blood-stasis syndrome type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

L-phenylalanine and UVA irradiation in the treatment of vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

PUVA and PUVB in vitiligo--are they equally effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Response of vitiligo to narrowband ultraviolet B and oral antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Serum antibodies in vitiligo patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Micropigmentation: tattooing for medical purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Non-psoralen treatment of vitiligo. Part II. Less commonly used and experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Psoralen photochemotherapy for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

NALP1 in vitiligo-associated multiple autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Psychologic effects of vitiligo: a critical incident analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Effect of vitiligo on self-reported health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Quality of life in patients with vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Dihydroxyacetone: a safe camouflaging option in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Autoimmunity as an aetiological factor in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

A systematic review of natural health product treatment for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Interventions for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Vitiligo treated with topical clobetasol propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

On the etiology of vitiligo and gray hair

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Psychological reaction to chronic skin disorders: a study of patients with vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

The effect of vitiligo on sexual relationships

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Genetic nature of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

1 reference

7 January 2021

The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Comparison of two surgical approaches for treating vitiligo: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

The treatment of vitiligo with psoralens and triamcinolone by mouth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol--a double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Micropigmentation for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Characterization of vitiligo antigens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

The genetics of generalized vitiligo and associated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Ultraviolet A in vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Combination of PUVAsol and Topical Calcipotriol in Vitiligo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003263.PUB4

7 January 2021

10.1002/14651858.CD003263.PUB4

Identifiers

DOI

0 references

Fatcat ID

release_ua6xbutelnfgpnqluqc7cop5hm

0 references